Precipio

In Brief This Week: Myriad Genetics, Precipio, LumiraDx, Guardant Health, and More

News items for the in vitro diagnostics industry for the week of Jan. 18, 2021.

In Brief This Week: Laboratory for Advanced Medicine, Prescient Metabiomics, Precipio, and More

Precipio to Effect 1-for-15 Reverse Stock Split

The cancer diagnostics developer said it was undertaking the reverse stock split in order to meet the Nasdaq's $1 minimum bid price requirement.

In Brief This Week: BioDirection, Quest Diagnostics, OncoCyte, and More

A brief recap of Diagnostics news the week of Feb 15, 2019: SpeeDX, Translational Software, PWN Health & Allscripts Healthcare Solutions, Immunovia, Curculogene, Fujirebio Diagnostics, Precipio

In Brief This Week: WHO, Cancer Genetics, Interpace Diagnostics, and More

Jan 11, 2019

In Brief This Week: Danaher, Natera, Chembio, and More

Dec 7, 2018

In Brief This Week: Precipio, OpGen, Genedrive, and Danaher

Nov 27, 2018

Lung Cancer Screening Study at UCMC to Utilize Precipio ICE-COLD PCR Tech

Nov 1, 2018

PerkinElmer, Precipio Collaborate On Liquid Biopsy Testing

Oct 16, 2018

Precipio Reports 140 Percent Jump in Preliminary Q3 Revenues

Sep 28, 2018

Precipio Gets Extension to Meet Nasdaq Listing Requirement

Jul 18, 2018

Precipio Posts Preliminary Q2 Revenue Growth of 213 Percent

Mar 13, 2018

Precipio Settles Lawsuit With Investment Group

Feb 27, 2018

Precipio Sued Over Transgenomic Securities Agreement

Nov 13, 2017

Precipio Completes Public Offering, Raises $2.7M

Nov 3, 2017

Precipio Diagnostics Prices $2.7M Direct Offering

Jun 30, 2017

In Brief This Week: Siemens Healthineers, Precipio Diagnostics, Transgenomic, Orig3n, and More

Jun 6, 2017

Transgenomic Shareholders Approve Merger With Precipio Dx

Apr 17, 2017

Transgenomic Closes Bridge Financing

Jan 12, 2017

LifeLabs Licenses Transgenomic Technology

Oct 13, 2016

Transgenomic, Precipio Diagnostics Ink Merger Agreement

Jul 20, 2016